NumerixS Investment Technologies’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-29,543
Closed -$2.9M 7
2020
Q2
$2.9M Buy
+29,543
New +$2.6M 0.81% 13
2020
Q1
Sell
-2,772
Closed -$245K 966
2019
Q4
$245K Buy
+2,772
New +$230K 0.05% 430
2019
Q1
Sell
-9,860
Closed -$898K 1105
2018
Q4
$898K Sell
9,860
-3,590
-27% -$316K 0.29% 64
2018
Q3
$1.27M Sell
13,450
-37,039
-73% -$3.51M 0.24% 104
2018
Q2
$4.67M Buy
50,489
+25,955
+106% +$2.53M 1.06% 3
2018
Q1
$2.31M Buy
24,534
+19,834
+422% +$2.18M 0.57% 36
2017
Q4
$455K Sell
4,700
-5,793
-55% -$546K 0.1% 229
2017
Q3
$932K Buy
+10,493
New +$799K 0.21% 104
2017
Q2
Sell
-83,498
Closed -$3.93M 1097
2017
Q1
$3.93M Buy
+83,498
New +$5.25M 0.45% 35
2016
Q4
Sell
-45,915
Closed -$2.9M 1089
2016
Q3
$2.9M Buy
+45,915
New +$2.97M 0.37% 46
2016
Q2
Sell
-82,939
Closed -$4.74M 1095
2016
Q1
$4.74M Buy
82,939
+61,947
+295% +$3.45M 0.55% 24
2015
Q4
$1.24M Buy
+20,992
New +$1.21M 0.15% 162
2015
Q3
Sell
-74,589
Closed -$5.01M 626
2015
Q2
$5.01M Buy
+74,589
New +$4.87M 0.67% 18
2015
Q1
Sell
-32,607
Closed -$2.13M 557
2014
Q4
$2.13M Buy
+32,607
New +$2.06M 0.72% 17

Other funds holding ABBV

NumerixS Investment Technologies's ABBV Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 29,543 shares — an estimated $2.9M sold.

NumerixS Investment Technologies first reported a position in ABBV in Q4 2014 and held it in 14 quarters. The position peaked at $5.01M in Q2 2015. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 29,543 AbbVie shares in Q3 2020, an estimated $2.9M.
  • NumerixS Investment Technologies first reported a position in AbbVie in Q4 2014 and held it in 14 quarters.
  • NumerixS Investment Technologies's AbbVie position peaked at $5.01M in Q2 2015.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.